March 2024 MHRA Safety Communications
The MHRA has published a summary of letters and notifications issued to healthcare professionals during March 2024 concerning medicines and medical devices. This update consolidates important safety information relevant to clinical practice across primary and secondary care.
Key Points
- Multiple safety communications were issued in March 2024 affecting various medicines and medical devices
- Healthcare professionals should review these alerts to ensure patient safety and appropriate prescribing decisions
- Some communications may relate to supply issues, efficacy concerns, or adverse event reporting
Recommended Actions
All healthcare professionals should:
- Review the full MHRA alert to identify any medicines or devices used in your clinical setting
- Check patient records for anyone currently prescribed affected medications
- Ensure relevant team members (pharmacy, nursing, medical staff) are aware of the updates
- Follow any specific guidance issued by the MHRA regarding patient management or product use
Access the Full Alert
For the complete list of affected medicines, specific safety concerns, and detailed guidance, view the MHRA alert on GOV.UK.
A summary is also available on first-responder.uk/news.